FBI Investigates Colts Owner Jim Irsay’s Death, Team Confirms Awareness

The Indianapolis Colts have acknowledged an ongoing FBI investigation into the death of their former owner, Jim Irsay. The team stated they are aware of the investigation but emphasized they have not been contacted by the FBI or served with any subpoenas.

FBI Investigates Jim Irsay’s Death: Key Details

The FBI’s inquiry follows reports by The Washington Post, which revealed a federal grand jury subpoena focusing on Irsay’s drug use and relationships, particularly with Dr. Harry Haroutunian, a recovery doctor from California.

Jim Irsay passed away at the age of 65 in May 2025, with his death certificate citing cardiac arrest due to pneumonia and heart complications. Notably, an autopsy was not performed.

Background on Jim Irsay

• Irsay had a long history of substance abuse issues.
• In March 2014, he was arrested for driving under the influence, with authorities discovering approximately $29,000 in cash and multiple bottles of prescription drugs in his vehicle.
• He was fined $500,000 by the NFL and faced a six-game suspension for violating conduct policies.

Haroutunian, who handled Irsay’s treatment prior to his death in Beverly Hills, had prescribed opioids and ketamine. The latter is controversial, creating discussions about its medical use alongside its potential for abuse.

Family and Advocacy

After Irsay’s death, his eldest daughter, Carlie Irsay-Gordon, became the principal owner of the Colts, supported by her sisters, Casey Foyt and Kalen Jackson, as co-owners. The family expressed their deep sense of loss and shared their father’s dedication to advocating for mental health and substance abuse awareness.

The Irsay family established the Kicking The Stigma initiative in 2020 to combat mental health stigma and raise awareness about related challenges. This advocacy reflects Irsay’s lifelong struggles and openness regarding addiction.

Investigation Insights

The FBI has begun interviewing close associates of Irsay as part of their investigation. Representatives of the bureau have declined to confirm the details surrounding the investigation due to policy restrictions, leaving many questions unanswered.

As the investigation unfolds, the focus remains on understanding the circumstances surrounding Irsay’s death and his relationship with medical professionals involved in his care.